These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30904209)

  • 1. In vitro comparison of efficacy of catheter locks in the treatment of catheter related blood stream infection.
    Visek J; Ryskova L; Safranek R; Lasticova M; Blaha V
    Clin Nutr ESPEN; 2019 Apr; 30():107-112. PubMed ID: 30904209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro comparison of the effectiveness of various antimicrobial locks with taurolidine in the treatment and prevention of catheter-related bloodstream infections in patients receiving parenteral nutrition.
    Visek J; Ryskova L; Machacova A; Marikova M; Blaha V
    Nutrition; 2023 Oct; 114():112115. PubMed ID: 37450960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
    Luther MK; Mermel LA; LaPlante KL
    J Antimicrob Chemother; 2014 Dec; 69(12):3263-7. PubMed ID: 25096074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Assessment of the Antimicrobial Efficacy of Optimized Nitroglycerin-Citrate-Ethanol as a Nonantibiotic, Antimicrobial Catheter Lock Solution for Prevention of Central Line-Associated Bloodstream Infections.
    Reitzel RA; Rosenblatt J; Hirsh-Ginsberg C; Murray K; Chaftari AM; Hachem R; Raad I
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5175-81. PubMed ID: 27297475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EDTA and Taurolidine Affect Pseudomonas aeruginosa Virulence
    Colombari B; Alfano G; Gamberini C; Cappelli G; Blasi E
    Microbiol Spectr; 2021 Dec; 9(3):e0104721. PubMed ID: 34787464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks.
    Olthof ED; Rentenaar RJ; Rijs AJ; Wanten GJ
    Clin Nutr; 2013 Aug; 32(4):538-42. PubMed ID: 23267744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of tigecycline and vancomycin activities in an in vitro biofilm model generated with methicillin-resistant Staphylococcus aureus].
    Aslan H; Yapar N
    Mikrobiyol Bul; 2015 Oct; 49(4):475-83. PubMed ID: 26649405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial Locks in Patients Receiving Home Parenteral Nutrition.
    Daoud DC; Wanten G; Joly F
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32050544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy.
    Chauhan A; Lebeaux D; Ghigo JM; Beloin C
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6310-8. PubMed ID: 23027191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of 2% taurolidine lock solution for treatment and prevention of catheter-related bloodstream infections in neonates: a feasibility study.
    Savarese I; Yazami S; De Rose DU; Carkeek K; Campi F; Auriti C; Danhaive O; Piersigilli F
    J Hosp Infect; 2024 Jan; 143():76-81. PubMed ID: 37972710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.
    Klek S; Szczepanek K; Hermanowicz A; Galas A
    JPEN J Parenter Enteral Nutr; 2015 Mar; 39(3):331-5. PubMed ID: 24604029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to Reduce Catheter-Related Bloodstream Infections in Pediatric Patients Receiving Home Parenteral Nutrition: The Efficacy of Taurolidine-Citrate Prophylactic-Locking.
    Lambe C; Poisson C; Talbotec C; Goulet O
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):1017-1025. PubMed ID: 29385236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
    Trials; 2018 May; 19(1):264. PubMed ID: 29720244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of a novel catheter lock solution.
    Shah CB; Mittelman MW; Costerton JW; Parenteau S; Pelak M; Arsenault R; Mermel LA
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1674-9. PubMed ID: 12019075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taurolidine locks significantly reduce the incidence of catheter-related blood stream infections in high-risk patients on home parenteral nutrition.
    Saunders J; Naghibi M; Leach Z; Parsons C; King A; Smith T; Stroud M
    Eur J Clin Nutr; 2015 Feb; 69(2):282-4. PubMed ID: 24642782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
    Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
    Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiocidal effects of various taurolidine containing catheter lock solutions.
    Olthof ED; Nijland R; Gülich AF; Wanten GJ
    Clin Nutr; 2015 Apr; 34(2):309-14. PubMed ID: 24861410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro efficacies of various catheter lock solutions.
    Sherertz RJ; Boger MS; Collins CA; Mason L; Raad II
    Antimicrob Agents Chemother; 2006 May; 50(5):1865-8. PubMed ID: 16641463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taurolidine lock is superior to heparin lock in the prevention of catheter related bloodstream infections and occlusions.
    Olthof ED; Versleijen MW; Huisman-de Waal G; Feuth T; Kievit W; Wanten GJ
    PLoS One; 2014; 9(11):e111216. PubMed ID: 25379781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.